A Distinct Subset of Proinflammatory Neutrophils Isolated from Patients with Systemic Lupus Erythematosus Induces Vascular Damage and Synthesizes Type I IFNs
Top Cited Papers
- 15 March 2010
- journal article
- Published by The American Association of Immunologists in The Journal of Immunology
- Vol. 184 (6), 3284-3297
- https://doi.org/10.4049/jimmunol.0902199
Abstract
Neutrophil-specific genes are abundant in PBMC microarrays from lupus patients because of the presence of low-density granulocytes (LDGs) in mononuclear cell fractions. The functionality and pathogenicity of these LDGs have not been characterized. We developed a technique to purify LDGs from lupus PBMCs and assessed their phenotype, function, and potential role in disease pathogenesis. LDGs, their autologous lupus neutrophils, and healthy control neutrophils were compared with regard to their microbicidal and phagocytic capacities, generation of reactive oxygen species, activation status, inflammatory cytokine profile, and type I IFN expression and signatures. The capacity of LDGs to kill endothelial cells and their antiangiogenic potential were also assessed. LDGs display an activated phenotype, secrete increased levels of type I IFNs, TNF-α, and IFN-γ, but show impaired phagocytic potential. LDGs induce significant endothelial cell cytotoxicity and synthesize sufficient levels of type I IFNs to disrupt the capacity of endothelial progenitor cells to differentiate into mature endothelial cells. LDG depletion restores the functional capacity of endothelial progenitor cells. We conclude that lupus LDGs are proinflammatory and display pathogenic features, including the capacity to synthesize type I IFNs. They may play an important dual role in premature cardiovascular disease development in systemic lupus erythematosus by simultaneously mediating enhanced vascular damage and inhibiting vascular repair.Keywords
This publication has 116 references indexed in Scilit:
- Peripheral blood gene expression profiling in Sjögren's syndromeGenes & Immunity, 2009
- Early atherosclerosis in systemic sclerosis and its relation to disease or traditional risk factorsArthritis Research & Therapy, 2008
- Augmented interferon‐α pathway activation in patients with Sjögren's syndrome treated with etanerceptArthritis & Rheumatism, 2007
- Type I interferon–inducible gene expression in blood is present and reflects disease activity in dermatomyositis and polymyositisArthritis & Rheumatism, 2007
- Interferon-α promotes abnormal vasculogenesis in lupus: a potential pathway for premature atherosclerosisBlood, 2007
- Haematopoietic and endothelial progenitor cells are deficient in quiescent systemic lupus erythematosusAnnals Of The Rheumatic Diseases, 2007
- Intrarenal cytokine gene expression in lupus nephritisAnnals Of The Rheumatic Diseases, 2007
- TLR9 signals after translocating from the ER to CpG DNA in the lysosomeNature Immunology, 2004
- Fcgamma and complement receptors: expression, role and co-operation in mediating the oxidative burst and degranulation of neutrophils of Brazilian systemic lupus erythematosus patientsLupus, 2002
- Derivation of the sledai. A disease activity index for lupus patientsArthritis & Rheumatism, 1992